How Can Good Research Practice Guidance Improve Health Technology Assessment?

Published Nov 6, 2017
Glasgow, Scotland, UK—6 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), focused on what aspects of health technology assessment (HTA) can be improved with good research practice guidance. The workshop, “Where Do We Need Good Research Practice Guidance in Health Technology Assessment?” [W1], was held this morning at the ISPOR 20th Annual European Congress in Glasgow, Scotland, UK. The session featured discussion leaders Finn Børlum Kristensen, MD, PhD, University of Southern Denmark, Hilleroed, Denmark; Mirjana Huić, MD, PhD, Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, Croatia; Wim Goettsch, PhD, The National Healthcare Institute, Diemen, The Netherlands; and Sophie Werkö, PhD, MSc, Swedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden. Post-regulatory approval evidence is increasingly informing population-based health care decisions. In this session, discussion leaders from the ISPOR Health Technology Assessment Council working group began with a global overview of existing good practices related to the translation of evidence to health care policy. Speakers then identified areas in which good research practice guidance is needed and how these areas might best be addressed at the European and global levels. The working group has conducted an overview of existing good practices related to translating evidence to policy from all regions of the world. The draft guidance document has already undergone two rounds of review, including a public review and comment stage. Additional information on the ISPOR 20th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the congress on social media using the hashtag #ISPORGlasgow.


  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: | LinkedIn: | Twitter: (@ISPORorg) | YouTube: | Facebook:

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now